+629.1%
MRNA vs BLDR
+395.5%
+233.6%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BLDR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.9% | -1.5% | -2.9% |
| 7D | -10.1% | -2.7% | -7.4% | -9.5% |
| 30D | +126.7% | -14.7% | +141.4% | +136.1% |
| 3M | +184.1% | -20.8% | +204.9% | +198.2% |
| 6M | +143.3% | -35.3% | +178.6% | +162.6% |
| YTD | +359.9% | -40.3% | +400.2% | +400.8% |
| 1Y | +454.2% | -56.3% | +510.5% | +530.8% |
| 3Y | +26.0% | -56.1% | +82.1% | +42.5% |
| 5Y | -70.3% | +12.9% | -83.2% | -68.3% |
| All | +629.1% | +395.5% | +233.6% | +620.8% |
Cumulative growth
Daily Returns
Daily percentage return beside BLDR.
Daily Out/Under-Performance
Portfolio return minus BLDR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BLDR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BLDR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling